Direct interaction of SOS1 ras exchange protein with the SH3 domain of phospholipase C-γ1

被引:47
作者
Kim, MJ
Chang, JS
Park, SK
Hwang, JI
Ryu, SH
Suh, PG [1 ]
机构
[1] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea
[2] Pohang Univ Sci & Technol, Sch Environm Engn, Pohang 790784, South Korea
[3] Daejin Univ, Dept Biol, Pochon Gun 487800, Kyeonggido, South Korea
[4] Daewoong Pharmaceut Co Ltd, R&D Ctr, Joowon Ku, Sungnam Kyungki Do 462120, South Korea
关键词
D O I
10.1021/bi992558t
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A recent report that microinjection of the SH3 domain of PLC-gamma 1 could induce DNA synthesis raised the functional importance of the SH3 domain of PLC-gamma 1 in mitogenic signaling. In this report, we provide evidence that SOS1, a p2Ras-specific guanine nucleotide exchange factor, directly binds to the SH3 domain of PLC-gamma 1, and that the SH3 domain of 1 is involved in SOS1-mediated p21Ras activation. SOS1 was coprecipitated with the GST-fused SH3 domain of PLC-gamma 1 in vitro. The interaction between SOS1 and the PLC-gamma 1 SH3 domain is mediated by direct physical interaction. The carboxyl-terminal proline-rich domain of SOS1 is involved in the interaction with the PLC-gamma 1 SH3 domain. Moreover, PLC-gamma 1 could be co-immunoprecipitated with SOS1 antibody in cell lysates. From transient expression studies, we could demonstrate that the SH3 domain of PLC-gamma 1 is necessary for the association with SOS1 in vivo. Intriguingly, overexpression of the SH3 domain of PLC-gamma 1, lipase-inactive PLC-gamma 1, or wild-type PLC-gamma 1 elevated p21Ras activity and ERK activity when compared with vector transfected cells. The PLC-gamma 1 mutant lacking the SH3 domain could not activate p21Ras. p21Ras activities in cell lines overexpressing either PLC-gamma 1 or the SH2-SH2-SH3 domain of PLC-gamma 1 were elevated about 2-fold compared to vector transfected cells. This study is the first to demonstrate that the PLC-gamma 1 SH3 domain enhances p21Ras activity, and that the SH3 domain of PLC-gamma 1 may be involved in the SOS1-mediated signaling pathway.
引用
收藏
页码:8674 / 8682
页数:9
相关论文
共 34 条
[1]   MEMBRANE TARGETING OF THE NUCLEOTIDE EXCHANGE FACTOR SOS IS SUFFICIENT FOR ACTIVATING THE RAS SIGNALING PATHWAY [J].
ARONHEIM, A ;
ENGELBERG, D ;
LI, NX ;
ALALAWI, N ;
SCHLESSINGER, J ;
KARIN, M .
CELL, 1994, 78 (06) :949-961
[2]   ELEVATED CONTENT OF THE TYROSINE KINASE SUBSTRATE PHOSPHOLIPASE C-GAMMA-1 IN PRIMARY HUMAN BREAST CARCINOMAS [J].
ARTEAGA, CL ;
JOHNSON, MD ;
TODDERUD, G ;
COFFEY, RJ ;
CARPENTER, G ;
PAGE, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10435-10439
[3]   INOSITOL TRISPHOSPHATE FORMATION AND CALCIUM MOBILIZATION IN SWISS 3T3 CELLS IN RESPONSE TO PLATELET-DERIVED GROWTH-FACTOR [J].
BERRIDGE, MJ ;
HESLOP, JP ;
IRVINE, RF ;
BROWN, KD .
BIOCHEMICAL JOURNAL, 1984, 222 (01) :195-201
[4]   INOSITOL TRISPHOSPHATE, A NOVEL 2ND MESSENGER IN CELLULAR SIGNAL TRANSDUCTION [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1984, 312 (5992) :315-321
[5]   EPIDERMAL GROWTH-FACTOR REGULATES P21(RAS) THROUGH THE FORMATION OF A COMPLEX OF RECEPTOR, GRB2 ADAPTER PROTEIN, AND SOS NUCLEOTIDE EXCHANGE FACTOR [J].
BUDAY, L ;
DOWNWARD, J .
CELL, 1993, 73 (03) :611-620
[6]  
Chang JS, 1997, CANCER RES, V57, P5465
[7]   HUMAN SOS1 - A GUANINE-NUCLEOTIDE EXCHANGE FACTOR FOR RAS THAT BINDS TO GRB2 [J].
CHARDIN, P ;
CAMONIS, JH ;
GALE, NW ;
VANAELST, L ;
SCHLESSINGER, J ;
WIGLER, MH ;
BARSAGI, D .
SCIENCE, 1993, 260 (5112) :1338-1343
[8]   Regulation of Sos activity by intramolecular interactions [J].
Corbalan-Garcia, S ;
Margarit, SM ;
Galron, D ;
Yang, SS ;
Bar-Sagi, D .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) :880-886
[9]   BINDING OF THE GRB2 SH2 DOMAIN TO PHOSPHOTYROSINE MOTIFS DOES NOT CHANGE THE AFFINITY OF ITS SH3 DOMAINS FOR SOS PROLINE-RICH MOTIFS [J].
CUSSAC, D ;
FRECH, M ;
CHARDIN, P .
EMBO JOURNAL, 1994, 13 (17) :4011-4021
[10]   Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras [J].
deRooij, J ;
Bos, JL .
ONCOGENE, 1997, 14 (05) :623-625